Holen Sie sich die Stockscreener-App
0.5348
1.27%
0.0067
Handel nachbörslich:
.54
0.0052
+0.97%
Schlusskurs vom Vortag:
$0.5281
Offen:
$0.5123
24-Stunden-Volumen:
184.56K
Relative Volume:
0.43
Marktkapitalisierung:
$22.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.56M
KGV:
-0.292
EPS:
-1.8316
Netto-Cashflow:
$-60.27M
1W Leistung:
-4.50%
1M Leistung:
-10.99%
6M Leistung:
+97.93%
1J Leistung:
-50.48%
1-Tages-Spanne:
$0.496
$0.54
1-Wochen-Bereich:
$0.49
$0.59
52-Wochen-Spanne:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Firmenname
Rallybio Corp
Sektor
Branche
Telefon
203- 859-3820
Adresse
234 CHURCH STREET, NEW HAVEN
Vergleichen Sie RLYB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.5348 | 22.07M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-07 | Herabstufung | Jefferies | Buy → Hold |
| 2023-04-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-10 | Eingeleitet | Wedbush | Outperform |
| 2022-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-08-23 | Eingeleitet | Cowen | Outperform |
| 2021-08-23 | Eingeleitet | Evercore ISI | Outperform |
| 2021-08-23 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Rallybio Corp Aktie (RLYB) Neueste Nachrichten
Risk adjusted return profile for Rallybio Corporation analyzedGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com
How Rallybio Corporation stock performs in rising dollar environmentWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Analyzing Rallybio Corporation with risk reward ratio chartsJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Is Rallybio Corporation stock reversal real or fake2025 Valuation Update & Precise Buy Zone Identification - newser.com
Rallybio (NASDAQ:RLYB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Rallybio Corporation stock outlook for YEAR2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Best data tools to analyze Rallybio Corporation stockGap Up & Weekly High Conviction Ideas - newser.com
What Fibonacci levels say about Rallybio Corporation rebound2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Is Rallybio Corporation stock attractive for growth ETFsWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com
Rallybio Corporation (NASDAQ:RLYB) Short Interest Update - Defense World
Will Rallybio Corporation stock benefit from automation2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Is it too late to sell Rallybio Corporation2025 Winners & Losers & Verified Technical Signals - newser.com
Analysts Set Rallybio Corporation (NASDAQ:RLYB) PT at $5.00 - Defense World
Using data tools to time your Rallybio Corporation exit2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Can Rallybio Corporation stock deliver sustainable ROEQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Top chart patterns to watch in Rallybio CorporationMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Rallybio Corporation Stock Analysis and ForecastMarket Capitalization Trends & You’ll Regret Not Buying These Early - earlytimes.in
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug - MSN
Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study By Investing.com - Investing.com Nigeria
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study - BioSpace
Finanzdaten der Rallybio Corp-Aktie (RLYB)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):